Baxter Raises Quarterly Dividend
DEERFIELD, Ill., November 9, 2010 - The Board of Directors of Baxter
International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.31 per
Baxter common share. This represents an increase of approximately 7 percent
over the previous quarterly rate of $0.29 per share. The dividend is payable on
January 5, 2011, to shareholders of record as of the close of business on
December 10, 2010.
Baxter continues to generate strong cash flow and has returned significant
value to shareholders in the form of dividends and share repurchases. Since the
beginning of 2010, Baxter has returned approximately $2.0 billion to shareholders
through dividends totaling $688 million and share repurchases of approximately
$1.3 billion (or 26 million shares).
"Our disciplined capital allocation strategy and ongoing ability to generate
strong cash flow allow us to continue to invest for the long-term while returning
significant value to our shareholders," said Robert J. Hombach, chief financial
officer.
Baxter International Inc., through its subsidiaries, develops, manufactures
and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic
and acute medical conditions. As a global, diversified healthcare company,
Baxter applies a unique combination of expertise in medical devices,
pharmaceuticals and biotechnology to create products that advance patient care
worldwide.
Media Contact:
Deborah Spak,
(847) 948-2349
Investor Contacts:
Mary Kay Ladone,
(847) 948-3371
Clare Trachtman,
(847) 948-3085
